Diagnostic and therapeutic implements based on advanced Biotechnology should be available in low-income countries
Acta Biomed
.
2019 Sep 30;90(10-S):5-6.
doi: 10.23750/abm.v90i10-S.8771.
Authors
Matteo Bertelli
1
,
Stefano Paolacci
,
Tommaso Beccari
,
Munis Dundar
,
Gabriella Sozanski
,
Stanislav Miertus
,
Jan Miertus
,
Lucio Luzzatto
Affiliation
1
EBTNA-LAB, Rovereto (TN), Italy; MAGI EUREGIO, Bolzano, Italy; Alliance for Health Promotion - in Official Relations with the World Health Organization (WHO), Geneva, Switzerland. matteo.bertelli@assomagi.org.
PMID:
31577247
PMCID:
PMC7233641
DOI:
10.23750/abm.v90i10-S.8771
Abstract
N.A.
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Biotechnology*
Developing Countries*
Health Services Accessibility*
Humans